These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29514663)

  • 1. Proteomic profiling of lung immune cells reveals dysregulation of phagocytotic pathways in female-dominated molecular COPD phenotype.
    Yang M; Kohler M; Heyder T; Forsslund H; Garberg HK; Karimi R; Grunewald J; Berven FS; Nyrén S; Magnus Sköld C; Wheelock ÅM
    Respir Res; 2018 Mar; 19(1):39. PubMed ID: 29514663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term smoking alters abundance of over half of the proteome in bronchoalveolar lavage cell in smokers with normal spirometry, with effects on molecular pathways associated with COPD.
    Yang M; Kohler M; Heyder T; Forsslund H; Garberg HK; Karimi R; Grunewald J; Berven FS; Magnus Sköld C; Wheelock ÅM
    Respir Res; 2018 Mar; 19(1):40. PubMed ID: 29514648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Airway regulatory T cells are decreased in COPD with a rapid decline in lung function.
    Eriksson Ström J; Pourazar J; Linder R; Blomberg A; Lindberg A; Bucht A; Behndig AF
    Respir Res; 2020 Dec; 21(1):330. PubMed ID: 33317530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in the T-cell profiles of the airways in COPD patients associated with clinical phenotypes.
    Forsslund H; Yang M; Mikko M; Karimi R; Nyrén S; Engvall B; Grunewald J; Merikallio H; Kaarteenaho R; Wahlström J; Wheelock ÅM; Sköld CM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():35-48. PubMed ID: 28053515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease.
    Kohler M; Sandberg A; Kjellqvist S; Thomas A; Karimi R; Nyrén S; Eklund A; Thevis M; Sköld CM; Wheelock ÅM
    J Allergy Clin Immunol; 2013 Mar; 131(3):743-51. PubMed ID: 23146379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Markers of Adaptive and Innate Immunity Are Associated with Chronic Obstructive Pulmonary Disease Severity and Spirometric Disease Progression.
    Halper-Stromberg E; Yun JH; Parker MM; Singer RT; Gaggar A; Silverman EK; Leach S; Bowler RP; Castaldi PJ
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):500-509. PubMed ID: 29206476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative proteomics analysis of patients with quick development and slow development Chronic Obstructive Pulmonary Disease (COPD).
    Li F; Xu D; Wang J; Jing J; Li Z; Jin X
    Life Sci; 2020 Sep; 256():117829. PubMed ID: 32454159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.
    Foreman MG; Wilson C; DeMeo DL; Hersh CP; Beaty TH; Cho MH; Ziniti J; Curran-Everett D; Criner G; Hokanson JE; Brantly M; Rouhani FN; Sandhaus RA; Crapo JD; Silverman EK;
    Ann Am Thorac Soc; 2017 Aug; 14(8):1280-1287. PubMed ID: 28380308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema.
    Löfdahl JM; Cederlund K; Nathell L; Eklund A; Sköld CM
    Eur Respir J; 2005 Feb; 25(2):275-81. PubMed ID: 15684291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.
    Kirby M; Tanabe N; Tan WC; Zhou G; Obeidat M; Hague CJ; Leipsic J; Bourbeau J; Sin DD; Hogg JC; Coxson HO; ; ;
    Am J Respir Crit Care Med; 2018 Jan; 197(1):56-65. PubMed ID: 28886252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic Analysis of Lung Tissue from Cigarette Smoke-Induced Emphysema Murine Models and Human Chronic Obstructive Pulmonary Disease Show Shared and Distinct Pathways.
    Yun JH; Morrow J; Owen CA; Qiu W; Glass K; Lao T; Jiang Z; Perrella MA; Silverman EK; Zhou X; Hersh CP
    Am J Respir Cell Mol Biol; 2017 Jul; 57(1):47-58. PubMed ID: 28248572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ratio of FEV
    Fortis S; Comellas AP; Bhatt SP; Hoffman EA; Han MK; Bhakta NR; Paine R; Ronish B; Kanner RE; Dransfield M; Hoesterey D; Buhr RG; Barr RG; Dolezal B; Ortega VE; Drummond MB; Arjomandi M; Kaner RJ; Kim V; Curtis JL; Bowler RP; Martinez F; Labaki WW; Cooper CB; O'Neal WK; Criner G; Hansel NN; Krishnan JA; Woodruff P; Couper D; Tashkin D; Barjaktarevic I
    Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study.
    Tan WC; Sin DD; Bourbeau J; Hernandez P; Chapman KR; Cowie R; FitzGerald JM; Marciniuk DD; Maltais F; Buist AS; Road J; Hogg JC; Kirby M; Coxson H; Hague C; Leipsic J; O'Donnell DE; Aaron SD;
    Thorax; 2015 Sep; 70(9):822-9. PubMed ID: 26048404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil and T cell markers predict functional decline in COPD patients.
    D'Armiento JM; Scharf SM; Roth MD; Connett JE; Ghio A; Sternberg D; Goldin JG; Louis TA; Mao JT; O'Connor GT; Ramsdell JW; Ries AL; Schluger NW; Sciurba FC; Skeans MA; Voelker H; Walter RE; Wendt CH; Weinmann GG; Wise RA; Foronjy RF
    Respir Res; 2009 Nov; 10(1):113. PubMed ID: 19925666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
    Strange C; Senior RM; Sciurba F; O'Neal S; Morris A; Wisniewski SR; Bowler R; Hochheiser HS; Becich MJ; Zhang Y; Leader JK; Methé BA; Kaminski N; Sandhaus RA;
    Ann Am Thorac Soc; 2015 Oct; 12(10):1551-60. PubMed ID: 26153726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative contributions of emphysema and airway remodelling to airflow limitation in COPD: Consistent results from two cohorts.
    Tho NV; Ryujin Y; Ogawa E; Trang le TH; Kanda R; Goto K; Yamaguchi M; Nagao T; Lan le TT; Nakano Y
    Respirology; 2015 May; 20(4):594-601. PubMed ID: 25788016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mixed phenotype of airway wall thickening and emphysema is associated with dyspnea and hospitalization for chronic obstructive pulmonary disease.
    Van Tho N; Ogawa E; Trang le TH; Ryujin Y; Kanda R; Nakagawa H; Goto K; Fukunaga K; Higami Y; Seto R; Wada H; Yamaguchi M; Nagao T; Lan le TT; Nakano Y
    Ann Am Thorac Soc; 2015 Jul; 12(7):988-96. PubMed ID: 25844673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.